Skip to main content
HR 1512 107th Congress House Health Access to health care Administrative procedure Administrative remedies Ambulatory care Auditing Budget surpluses Business records Capitation (Medical care) Catastrophic health insurance Civil Rights and Liberties, Minority Issues Coinsurance Commerce Competitive bidding Congress Congressional investigations Congressional reporting requirements Consumer education Cost control Counterfeiting

Medicare Extension of Drugs to Seniors (MEDS) Act of 2001

Introduced: April 4, 2001 Introduced by: Sanders, Bernard Independent · Vermont See on congress.gov
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 25, 2001
Referred to the Subcommittee on Health.
Apr 24, 2001
Referred to the Subcommittee on Health.
Apr 4, 2001
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 4, 2001
Introduced in House
 Plain-English summary Congressional Research Service
Medicare Extension of Drugs to Seniors (MEDS) Act of 2001 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to add a new part D (Prescription Medicine Benefit for the Aged and Disabled) establishing a voluntary insurance program to provide prescription medicine benefits, including pharmacy services, for eligible individuals (including low-income individuals) who are aged or disabled or have end-stage renal disease, and who elect to enroll during a prescribed period, to be financed from monthly premium payments by enrollees together with Federal appropriations. Creates the Prescription Medicine Insurance Account within the Federal Supplemental Medical Insurance Trust Fund. Directs the Secretary of Health and Human Services to develop and implement an Employer Incentive Program that encourages employers to provide adequate prescription medicine benefits to retired individuals and maintain such existing benefit programs.

Outlines provisions for substantial reductions in the price of prescription drugs for Medicare beneficiaries.

Amends the Federal Food, Drug, and Cosmetic Act, as amended by the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2001, with respect to the importation of certain prescription drugs, to revise testing requirements (granting the Secretary certain waiver discretion) and add approved labeling requirements.

Requires the recipient of a patent to make a reasonable pricing agreement with the Secretary (or the Secretary to waive such an agreement in the public interest) if any Federal agency or any non-profit entity: (1) undertakes federally funded health care research and development; and (2) is to convey or provide a patent or other exclusive right to use such research and development for a drug or other health care technology.

What's happening now April 25, 2001

Referred to the Subcommittee on Health.

 Committees of jurisdiction 4